(Q51354299)

4 April 2018

title

Endogenous opioids, placebo response, and pain. (English)

1 reference

4 April 2018

0 references

1 reference

D J Rowbotham

1

1 reference

4 April 2018

language of work or name

English

0 references

publication date

1 June 2001

1 reference

4 April 2018

published in

The Lancet

1 reference

4 April 2018

volume

357

1 reference

4 April 2018

issue

9272

1 reference

4 April 2018

page(s)

1901-1902

1 reference

4 April 2018

Narcotic analgetics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905090-X

7 January 2021

Anatomy of CNS opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905090-X

7 January 2021

Opioid receptors and their ligands: natural and unnatural

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905090-X

7 January 2021

A potent and selective endogenous agonist for the mu-opiate receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905090-X

7 January 2021

Endomorphin-1 and endomorphin-2: pharmacology of the selective endogenous mu-opioid receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905090-X

7 January 2021

Analgesic efficacy of peripheral opioids (all except intra-articular): a qualitative systematic review of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905090-X

7 January 2021

Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905090-X

7 January 2021

Pharmacology of nociceptin and its receptor: a novel therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905090-X

7 January 2021

Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905090-X

7 January 2021

The mechanism of placebo analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905090-X

7 January 2021

Is placebo analgesia mediated by endogenous opioids? A systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905090-X

7 January 2021

An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905090-X

7 January 2021

The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905090-X

7 January 2021

Age and the pharmacokinetics of morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905090-X

7 January 2021

Kappa-opioids produce significantly greater analgesia in women than in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905090-X

7 January 2021

Response variability to analgesics: a role for non-specific activation of endogenous opioids.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905090-X

7 January 2021

Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905090-X

7 January 2021

10.1016/S0140-6736(00)05090-X

Identifiers

DOI

1 reference

4 April 2018

PubMed ID

11425407

1 reference

4 April 2018